Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Navelbine (Vinorelbine) Injection
Company:  Glaxo Wellcome Inc.
Application No.:  20-388/S8
Approval Date: 6/8/2000


Date created: June 19, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.